Several studies have found that the ERBB3 gene is primarily involved in SMD through the ErbB signalling, MAPK signalling, and PI3K-Akt signalling pathways.60 The gene discussed is EGFR; the disease is spondyloepimetaphyseal dysplasia, Strudwick type.